PTEN and cancer: We did not observe a significant difference in the prevalence of PTEN mutations between cases with a single PIK3CA mutation and those with multiple PIK3CA mutations across all cancer types, likely because PTEN mutations are common driver mutations in endometrial cancer; therefore, their occurrence is more likely to be tumor‐specific rather than being associated with the number of PIK3CA mutations.